COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia.

COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696.

View in: PubMed

subject areas

Aged
Antibodies, Monoclonal, Humanized
Anti-Inflammatory Agents
C-Reactive Protein
Dose-Response Relationship, Drug
Drug Monitoring
Female
Fever
Humans
Male
Pneumonia, Viral
Receptors, Interleukin-6
Severity of Illness Index
Time Factors
Treatment Outcome

authors with profiles

Theodore Karrison
Pankti Reid
Mary Elizabeth Strek
Cuoghi Edens
Thomas F. Gajewski
Mark J. Ratain
Iazsmin Ventura
Jennifer C. Pisano
Jonathan Trujillo